3 Dirt Cheap Stocks to Buy Right Now
By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found.
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and (NYSE: PFE).
Prosper Junior Bakiny (CRISPR Therapeutics): Valuing relatively small biotech companies that generate little-to-no revenue is not an exact science. Even so, CRISPR Therapeutics, a gene-editing specialist, looks cheap at its current levels. CRISPR Therapeutics' market cap is $4.2 billion despite the recent approval of Casgevy, a treatment for two blood-related diseases it developed in collaboration with Vertex Pharmaceuticals.
Source Fool.com
Pfizer Inc. Stock
With 29 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 40 € there is a hugely positive potential of 53.64% for Pfizer Inc. compared to the current price of 26.04 €.